Rockwell Medical, Inc. (RMTI): Cash & Equivalents
$10.71M
As of 2025-12-31
$10.52M
As of 2026-06-30
+2.0%
3-year compound annual growth
-26.1%
5-year compound annual growth
-10.1%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.71M | -31.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $15.66M | +74.4% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $8.98M | -11.1% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $10.10M | -23.9% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $13.28M | -72.7% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $48.68M | +312.7% | 2022-04-08, Balance as of period end |
| 2019-12-31 | $11.79M | -48.1% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $22.71M | +170.2% | 2020-03-17, Balance as of period end |
| 2017-12-31 | $8.41M | -51.1% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $17.18M | -44.9% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $31.20M | -52.6% | 2018-03-15, Balance as of period end |
| 2014-12-31 | $65.80M | +453.8% | 2017-03-15, Balance as of period end |
| 2013-12-31 | $11.88M | +152.2% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $4.71M | -17.6% | 2015-03-03, Balance as of period end |
| 2011-12-31 | $5.72M | -53.4% | 2014-03-07, Balance as of period end |
| 2010-12-31 | $12.26M | -46.8% | 2013-03-18, Balance as of period end |
| 2009-12-31 | $23.04M | n/a | 2012-03-05, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $10.71M | -31.6% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $149.10M | -33.6% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $40.27M | -23.9% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $58.45M | +52.4% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $628.11M | -28.6% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $32.30M | -13.3% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $128.51M | -17.8% |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $79.38M | +38.6% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $12.67M | -66.7% |
Compare RMTI, KURA, SPRO, ASMB side by side · Screen every company in Pharmaceutical Preparations ↗